Nan Sethakorn

Clinical trials

• Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

  Site PI · Recruiting · Phase 2

  SWOG Cancer Research Network

  2025–2029
• Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  Site PI · Recruiting · Phase 3

  National Cancer Institute (NCI)

  2025–2039
• Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  Site PI · Recruiting · Phase 2

  SWOG Cancer Research Network

  2024–2028
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  Site PI · Recruiting · Phase 2

  National Cancer Institute (NCI)

  2023–2030